Cape Verde vs New Zealand: Treatment success rate for patients treated for MDR-TB
Cape Verde
100.0%
in 2022
New Zealand
100.0%
in 2022
Cape Verde rank
1st
New Zealand rank
1st
Treatment success rate for patients treated for MDR-TB over time
- Cape Verde
- New Zealand
How they compare
Cape Verde currently reports 100.0% against 100.0% in New Zealand, a difference of 0.0%.
The two have swapped places 1 time across 6 shared years of data; in 2014 it was Cape Verde ahead.
Cape Verde ranks 1st and New Zealand ranks 1st of 163 countries.
Cape Verde has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cape Verde | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 83.2% | 16.8% | Cape Verde |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Cape Verde or New Zealand?
- Cape Verde, at 100.0% against 100.0% in New Zealand as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Cape Verde and New Zealand?
- 0.0%, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and New Zealand?
- 6 years are reported by both, from 2014 to 2022.
- How do Cape Verde and New Zealand rank globally for treatment success rate for patients treated for mdr-tb?
- Cape Verde ranks 1st and New Zealand ranks 1st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.